#ACR21 Abst#0271. ⬆️ Risk of carotid atherosclerosis in first few years of RA diagnosis. Authors recommend routine carotid screening in pts at time of diagnosis. Q: would you routinely screen all patients at time of diagnosis? @Rheumnow https://t.co/A9akqyVRGF https://t.co/SYGkJHQzWf

• https://bit.ly/3nWKWEc

PsA bDMARD use in Australia🇦🇺 (where once you qualify for a bDMARD in general, it's the physician's free choice) 1. cool Sankey diagram showing switches 2. given the chance, people switch in all directions & switch hard (registry linked with insurance) #ACR21 ABST0201 @RheumNow https://t.co/jcVPa8jXsR

COVID-19 has been tough on everyone, but especially tough on our patients in rheumatology. We need to think about the long-term impacts, but also about how we can do it better next time. @HSpecialSurgery #ACR21 ABST0266 @RheumNow https://t.co/JdOqZ8Svin https://t.co/c0rlY9PfDv

• The Psychosocial Impact of the COVID-19 Pandemic on the Rheumatology Patient Ex…

STEP-KOA trial: a promising intervention for knee #osteoarthritis?🤔 @RheumNow #ACR21 #YearinReview https://t.co/6Vkx0WR0tx

Abst#0276: Pulse Pressure (PP) can predict carotid plaque in RA! ➡️PP (SBP – DBP) assoc w/ subclinical CVD in gen populat. How about in RA? ⭐︎ RA pts had higher PP than controls ⭐︎ PP = only independent RF for subclinical athero #ACR21 @Rheumnow https://t.co/esLDW8iggf https://t.co/6d2D9hXC1i

• Pulse Pressure as a Predictor of Carotid Plaque in Rheumatoid Arthritis Patient…

Nintedanib open-label extension study in PF-ILD (progressive fibrosing) - active arm continuing: similar rate of change as RCT (78 v 77) - placebo arm initiating: similar as well Missing data (COVID-19) but effect appears related to exposure INBUILD-ON #ACR21 ABST0186 @RheumNow https://t.co/hWe7ypbex6

Abst#0269: Autoabs confer risk of incident CVD in US ⚦ veterans w/ RA ⭐︎ MACE risk: ↑ concentrations of RF (HR 1.15) & malondialdehyde acetaldehyde (anti-MAA) (HR 1.2) ⭐︎ CVD Death: ↑ concentrations of CCP (HR 1.27) & anti-MAA #ACR21 @Rheumnow https://t.co/UeOz91Bh3P https://t.co/PJwP1H4eNk

• Autoantibodies and the Risk of Incident Cardiovascular Disease in US Veterans w…

How it started How it's going inspirational talk @DzifaDey, building rheumatology up in Ghana, smart solutions across all domains, and scaling up to help across West Africa #ACR21 'Challenges & Innovation in Global Rheumatology' session @RheumNow @TheLancetRheum https://t.co/9aG6pes4qy https://t.co/wo6f90ocEP

• AFLAR on Twitter: "What a wonderful day of global Rheumatology at the #ACR…

💻 Telemedicine: would you rather have a telephone or a video clinics? Non inferiority RCT shows 80% satisfaction rates and phone-only non-inferior to video visits. I would have expected patients to prefer video visits 🧐 #ACR21 #Abst0112 @RheumNow https://t.co/klgMJ6EthH https://t.co/17ffTAZCfv

• A Randomized Trial Showing No Differences in Patient Satisfaction with Telemedi…

#ACR21 Abst#0269 ⭐️TCZ: ⬆️cholesterol, LDL, TG. ⬇️ hsCRP compared to TNFi. No ⬆️ risk of Reynold risk score (RRS) Take-away: good data on TCZ effect on lipids, but I wouldn't use RRS to calculate CVD risk on med that ⬇️ CRP @Rheumnow https://t.co/zMltktfHkS https://t.co/bwKXiGIi8a

• https://bit.ly/300pdTP

#Abstr0076 #ACR21 Can we predict #thrombosis in #lupus patients? Predictors of serology transition at 5yrs: ✅LAC+ to LAC-:Afro-American,HCQ and normal C3 ⛔️LAC+ to 🩸Clot:Obesity, low C3 and not on HCQ Data need in those with Triple Positivity @RheumNow https://t.co/byeL5NjVUS https://t.co/CchtZir2GN

• Predicting the Transitions Between Lupus Anticoagulant Status and Thrombosis in…

#Abstr0002 #ACR21 What drives salt in saliva in #sjogren? A study suggested Bcell cytokines mediated the epithelial Na+ Channel disruption. A case for targeting Bcell to improve oral health @RheumNow https://t.co/Bx3kBpOIFX https://t.co/YYnC6UoMJY

• Salivary Sodium Levels in the Parotid Salivary Gland of SS Patients Suggest B-c…

Abst#0268 ➡️Do lipids change w/ some bDMARDs in RA? YES! ⭐︎ TCZ: ↑ TC, LDL, TG & ↓ in hsCRP relative to initiating TNFi. ➡️Does this lipid ↑ confer risk for CVD? Not necessarily as it may not be atherogenic per Reynolds Risk Score! #ACR21 @Rheumnow https://t.co/Gy62mg6GhZ https://t.co/5uC8Zy0Lbr

• Effect of Biologic Agents on Lipids and Cardiovascular Risk in Rheumatoid Arthr…

Which of the following would you d/c in the 3rd trimester of pregnancy? #ACR21 #Pregnancy @rheumnow

Experts (Drs. M Clowse, Sammaratino) limit mAb TNFi 1 month b/f delivery or extend dosing. But, they do dose again for flares. Risk for infection is low based on the PIANO registry. Postpartum, they restart the meds w/in 1 week (vag delivery), 2 weeks C/S @rheumnow #pregnancy